---
$id: https://graph.org.ai/products/commodity/51202412
$type: Product
source: UNSPSC
code: "51202412"
title: "Omalizumab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Omalizumab

**UNSPSC Code**: 51202412
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6450H9916N1714O2023S38, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2P471X1Z11, more generally known as omalizumab. European Medicines Agency schedules omalizumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12543MIG. The term OMALIZUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. Most nations, for tariff and trade purposes, schedule Omalizumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, OMALIZUMAB remains US FDA's Preferred Term for this commodity. . Omalizumab bears US NLM identifiers UMLS ID C0910794 and NCI Concept Code C29299.

